BlockShare.it BlockShare.it
Risultati di ricerca
Mostra tutti i risultati
  • Iscriviti
    Accedi
    Iscriviti
    Cerca
    Night Mode

Cerca

Scopri nuove persone e i loro amici a quattro zampe, e fai nuove amicizie

  • Notizie
  • EXPLORE
  • Pagine
  • Gruppi
  • Eventi
  • Blogs
  • Marketplace
  • Jobs
  • Forums
  • Movies
  • Developers
  • Articoli
  • Articles
  • Utenti
  • Pagine
  • Gruppi
  • Eventi
  • Emma Verghise ha aggiunto un file Home
    2025-06-19 07:02:30 -
    Expanding Applications Drive Growth in the Global GLP-1 Market
    The GLP-1 market is experiencing a robust surge in demand globally, driven by the increasing burden of type 2 diabetes and obesity, rising public awareness of metabolic health, and growing adoption of novel non-insulin therapies. Glucagon-like peptide-1 (GLP-1) analogs and receptor modulators have become a cornerstone in modern diabetes management and weight reduction programs, especially as...
    0 Commenti 0 condivisioni
    Effettua l'accesso per mettere mi piace, condividere e commentare!
  • Emma Verghise ha aggiunto un file Home
    2025-06-19 07:02:32 -
    Expanding Applications Drive Growth in the Global GLP-1 Market
    The GLP-1 market is experiencing a robust surge in demand globally, driven by the increasing burden of type 2 diabetes and obesity, rising public awareness of metabolic health, and growing adoption of novel non-insulin therapies. Glucagon-like peptide-1 (GLP-1) analogs and receptor modulators have become a cornerstone in modern diabetes management and weight reduction programs, especially as...
    0 Commenti 0 condivisioni
    Effettua l'accesso per mettere mi piace, condividere e commentare!
  • Emma Verghise ha aggiunto un file Home
    2025-09-05 19:15:09 -
    Regional Manufacturing Trends and Cross-Border Supply Chains Drive GLP-1 Market Expansion
    The global GLP-1 market, valued at USD 47.74 billion in 2024, is projected to grow at a compound annual growth rate (CAGR) of 10.9% from 2025 to 2034, driven by the rising prevalence of type 2 diabetes, obesity, and metabolic syndrome, coupled with the expanding therapeutic applications of glucagon-like peptide-1 (GLP-1) receptor agonists. These injectable biologics—originally developed...
    0 Commenti 0 condivisioni
    Effettua l'accesso per mettere mi piace, condividere e commentare!
© 2026 BlockShare.it Italiano
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
Tuo LinkRef About Termini e Condizioni Privacy Contattaci Elenco